Children's Hospices Across Scotland
Children's Hospices Across Scotland
Children's Hospices Across Scotland (CHAS) is a Scottish charity that provides hospice services for children and young people with life-shortening conditions. CHAS offers a full family support service for babies, children, and young people, both in hospice settings and in their own homes.
History
CHAS was established in 1992 to address the need for specialized hospice care for children in Scotland. The organization has grown to operate two hospices: Rachel House in Kinross and Robin House in Balloch. These facilities provide a range of services including respite care, end-of-life care, and bereavement support.
Services
CHAS provides comprehensive support to families, including:
- Respite Care: Offering families a break from the demands of caring for a child with a life-shortening condition.
- End-of-Life Care: Providing compassionate care and support during the final stages of a child's life.
- Bereavement Support: Helping families cope with the loss of a child through counseling and support groups.
- Home Care: Delivering care and support in the family's home, allowing children to remain in familiar surroundings.
Facilities
CHAS operates two main hospices:
- Rachel House: Located in Kinross, it was the first children's hospice in Scotland, opening in 1996. It offers a welcoming environment with facilities such as a hydrotherapy pool, sensory room, and family accommodation.
- Robin House: Situated in Balloch, it opened in 2005 and provides similar facilities and services as Rachel House, with additional features like a music therapy room and extensive gardens.
Community and Volunteer Support
CHAS relies heavily on the support of volunteers and the community. Volunteers assist in various roles, from fundraising to providing direct support to families. Community fundraising events are crucial for sustaining the services CHAS offers.
Related Pages
Template:Children's charities in the United Kingdom Template:Hospices in the United Kingdom
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD